Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/MANKIND stock hub

NSE/MANKIND has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/MANKINDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/MANKIND

In the news

Latest news · NSE/MANKIND

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E43.4

P25 24.9P50 32.4P75 45.7

Trailing P/E56.3

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC10.1

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/MANKIND market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

173

Groups with data

Currency

INR

Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	19,620
Employees Change	80%
Employees Change Percent	0.41
Enterprise value	INR 1.1T
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE634S01028
Last refreshed	2026-05-10
Market cap	INR 1T
Price	INR 2,423
Price currency	INR
Rev Per Employee	7,091,783.89x
Sector	Healthcare
Sic	2834
Symbol	nse/MANKIND
Website	https://www.mankindpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.77%
EV Earnings	59.27x
EV/EBIT	42.22x
EV/EBITDA	32.4x
EV/Sales	7.58x
Forward P/E	43.38x
P/B ratio	6.46x
P/E ratio	56.26x
P/S ratio	7.21x
PE Ratio3 Y	49.57x
PEG ratio	2.77x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	17.87%
EBITDA Margin	23.24%
Gross margin	70.25%
Gross Profit	INR 97.7B
Gross Profit Growth	19.64%
Gross Profit Growth Q	12.83%
Gross Profit Growth3 Y	20.82%
Net Income	INR 17.8B
Net Income Growth	-12.84%
Net Income Growth Q	7.5%
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Net Income Growth3 Y	14.46%
Pretax Margin	15.73%
Profit Margin	12.79%
Profit Per Employee	INR 906,906
Profitable Years	7
Roa5y	12.52
Roe5y	22.86
ROIC	10.07
Roic5y	26.72

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-0.35%
EPS Growth	-15.18
EPS Growth Q	4.77
EPS Growth Quarters	1
EPS Growth Years	2
EPS Growth3 Y	13.33
Revenue Growth	19.53x
Revenue Growth Q	10.44x
Revenue Growth Quarters	12x
Revenue Growth Years	6x
Revenue Growth3 Y	18.21x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 35B
Debt	INR 83.7B
Debt EBITDA	INR 2.58
Debt Equity	INR 0.54
Equity	INR 155.3B
Interest Coverage	3.66
Net Cash	INR -48.7B
Net Cash By Market Cap	INR -4.85
Net Debt EBITDA	INR 1.51
Net Debt Equity	INR 0.31
Tangible Book Value	INR -10.5B
Tangible Book Value Per Share	INR -25.46
WACC	6.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.76%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	INR 2
Dividend Years	1
Dividend Yield	0.08%
Last Dividend	INR 1

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-0.35%
200-day SMA	2,299.4
50-day SMA	2,150
50-day SMA vs 200-day SMA	50under200
All Time High	3,054.8
All Time High Change	-20.68%
All Time High Date	2024-12-23
All Time Low	1,242
All Time Low Change	95.09%
All Time Low Date	2023-05-22
ATR	62.23
Beta	0.47
Beta1y	0.54
Beta2y	0.34
Ch YTD	10.31
High	2,464.9
High52	2,716.5
High52 Date	2025-07-15
High52ch	-10.8%
Low	2,377.8
Low52	1,909.7
Low52 Date	2026-03-23
Low52ch	26.88%
Ma50ch	12.7%
Price vs 200-day SMA	5.37%
RSI	78.6
RSI Monthly	56.59
RSI Weekly	61.72
Sharpe ratio	0.04x
Sortino ratio	0.31
Total Return	-2.67%
Tr YTD	10.31
Tr1m	18.77%
Tr1w	7.32%
Tr3m	17.61%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 24.9B
Operating Income Growth	1.21
Operating Income Growth Q	9.31
Operating Income Growth3 Y	17.75
Operating margin	17.87

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	112,827,256%
Shares Insiders	57.71%
Shares Institutions	21.5%
Shares Out	412,828,328
Shares Qo Q	0.03%
Shares Yo Y	2.76%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	485,157.65x
Bv Per Share	370.3
Ch1m	18.77
Ch1w	7.32
Ch1y	-0.39
Ch3m	17.61
Ch6m	7.13
Change	2.01%
Change From Open	1.9
Close	2,375.2
Days Gap	0.11
Depreciation Amortization	7,459,325,000
Dollar Volume	2,614,160,162
Earnings Date	2026-05-19
EBIT	INR 24.9B
EBITDA	INR 32.3B
EPS	INR 43.1
F Score	2
Fiscal Year End	March
Founded	1,991
Graham Number	599.21673
Graham Upside	-75.27
Income Tax	INR 3.8B
Is Primary Listing	1
Last Earnings Date	2026-02-03
Last Report Date	2025-12-31
Lynch Fair Value	INR 623
Lynch Upside	-74.27
Ma150	2,212.1
Ma150ch	9.53%
Ma20	2,224.1
Ma20ch	8.94%
Next Earnings Date	2026-05-19
Open	2,377.8
Payment Date	2025-08-30
Position In Range	51.89
Price Date	2026-05-08
Price EBITDA	INR 31.04
Relative Volume	2.33x
Revenue	139,140,800,000x
Tax By Revenue	2.74x
Tax Rate	17.42%
Tr6m	7.13%
Volume	1,078,894

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/MANKIND dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.1%

$2.00 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

-2.7%

Dividend yield + buyback yield combined

Performance

NSE/MANKIND stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/MANKIND?

Insider, institutional, and short-interest positioning.

Institutional ownership

+21.5%

Share of float held by funds and institutions

Insider ownership

+57.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+2.8%

Negative means the company is buying back shares.

Technical

NSE/MANKIND momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

78.6

Above 70: short-term overbought

Price vs 200-day MA

+5.4%

50/200-day relationship not available

Beta (5Y)

0.47

Less volatile than the market

Sharpe ratio

0.04

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/MANKIND

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/MANKIND stock rating?

nse/MANKIND is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/MANKIND analysis?

The full report lives at /stocks/nse/MANKIND/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/MANKIND?

The latest report frames nse/MANKIND around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/MANKIND page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.